A
Angelo Branzi
Researcher at University of Bologna
Publications - 350
Citations - 17546
Angelo Branzi is an academic researcher from University of Bologna. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 58, co-authored 350 publications receiving 16425 citations.
Papers
More filters
Journal ArticleDOI
Comparison of All-Cause Mortality in Women With Known or Suspected Coronary Artery Disease Referred for Dobutamine Stress Echocardiography With Normal Versus Abnormal Test Results
Elena Biagini,Abdou Elhendy,Arend F.L. Schinkel,Vittoria Rizzello,Ron T. van Domburg,Boudewijn J. Krenning,Olaf Schouten,Fabiola B. Sozzi,Angelo Branzi,Guido Rocchi,Maarten L. Simoons,Jeroen J. Bax,Don Poldermans +12 more
TL;DR: The presence of myocardial ischemia during dobutamine stress echocardiography is independently associated with an increased risk of all-cause mortality in women after adjustment for clinical data.
Journal ArticleDOI
Recent temporal trends for first-time hospitalization for acute myocardial infarction. Treatment patterns and clinical outcome in a large cohort study
Paolo Ortolani,Massimiliano Marino,Giovanni Melandri,Paolo Guastaroba,Alessandro Corzani,Elena Berti,Claudio Rapezzi,Rossana De Palma,Angelo Branzi +8 more
TL;DR: A large retrospective population-based cohort study using medical administrative data ( International Classification of Diseases, Ninth Revision, Clinical Modification, codes) performed in the Emilia-Romagna Region of Italy (approximately 4.5 million inhabitants) was performed in this article.
Journal ArticleDOI
Effect of fluvastatin on long-term outcome after coronary revascularization with stent implantation☆
Francesco Saia,Francesco Saia,Pim J. de Feyter,Patrick W. Serruys,Pedro A. Lemos,Chourmouzios A. Arampatzis,Guy R. Hendrickx,Nicholas Delarche,Dick Goedhart,Emmanuel Lesaffre,Angelo Branzi +10 more
TL;DR: During the 4-year follow-up period, fluvastatin significantly decreased total cholesterol and low-density lipoprotein cholesterol levels and decreased the risk of first adverse atherosclerotic cardiac events by 30% compared with placebo.
Book ChapterDOI
Autocrine and intracrine signaling for cardiogenesis in embryonic stem cells: a clue for the development of novel differentiating agents.
Carlo Ventura,Angelo Branzi +1 more
TL;DR: The identification of cardiogenic mechanisms as a clue for the development of unprecedented differentiating strategies and sets the basis for the design of a novel generation of chemicals suited for the organization of targeted lineage patterning in stem cells.